This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Loeys–Dietz syndrome | |
|---|---|
| Name | Loeys–Dietz syndrome |
| Field | Medical genetics |
| Duration | Lifelong |
| Causes | Mutations in TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3 |
| Diagnosis | Genetic testing, imaging |
| Treatment | Surgical repair, medical therapy |
| Prognosis | Variable; risk of aortic dissection and aneurysm |
Loeys–Dietz syndrome is a rare autosomal dominant connective tissue disorder characterized by widespread vascular aneurysms, craniofacial and skeletal manifestations, and a propensity for early-life aortic dissection. It results from pathogenic variants in genes encoding components of the transforming growth factor-beta signaling pathway and requires multidisciplinary care involving cardiovascular surgeons, medical geneticists, and radiologists. Management emphasizes surveillance imaging, timely surgical intervention, and targeted medical therapy to reduce arterial complications.
Affected individuals present with arterial aneurysms and arterial tortuosity that may involve the aorta, cerebral arteries, and visceral vessels; clinical recognition often involves cardiothoracic teams at centers such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital. Craniofacial features include hypertelorism, bifid uvula, and cleft palate prompting consultations with specialists from Boston Children's Hospital, Great Ormond Street Hospital, Royal Children's Hospital (Melbourne), Seattle Children's Hospital. Skeletal manifestations—pectus excavatum, scoliosis, joint laxity—lead to referrals to orthopedic units at Hospital for Special Surgery, Rothman Orthopaedics, Shriners Hospitals for Children, Rizzoli Orthopedic Institute. Dermatologic findings such as translucent skin and easy bruising involve dermatopathology services at Mayo Clinic Arizona, Stanford Health Care, UCSF Medical Center, Mount Sinai Hospital (New York). Neurovascular events including stroke or subarachnoid hemorrhage engage neurosurgery teams from Barrow Neurological Institute, Johns Hopkins Neurosurgery, UCLA Health, Toronto Western Hospital. Other comorbidities—valvular heart disease, spontaneous pneumothorax, and intestinal malrotation—are managed in tertiary centers such as Children's Hospital of Philadelphia, Cedars-Sinai Medical Center, Royal Free Hospital, Karolinska University Hospital.
Pathogenic variants identified in genes TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3 underlie the disorder; molecular confirmation is often performed by laboratories at Invitae, Ambry Genetics, GeneDx, Laboratory Corporation of America and interpreted in collaboration with clinical genetics teams at NIH Clinical Center, Great Ormond Street Hospital, Sheffield Children's NHS Foundation Trust, Hôpital Necker-Enfants Malades. Dysregulated transforming growth factor-beta signaling leads to extracellular matrix remodeling and medial degeneration of arteries, a mechanism studied at research institutions including Howard Hughes Medical Institute, Broad Institute, Salk Institute, Cold Spring Harbor Laboratory. Animal models developed at University of Pennsylvania, University of Texas Southwestern Medical Center, University of California Los Angeles have elucidated SMAD-dependent and SMAD-independent pathways; work from groups at Massachusetts Institute of Technology, University of Cambridge, Karolinska Institutet implicates altered collagen and elastin fibrillogenesis. Genetic counseling is provided by teams at Genetics Clinic at Boston Children's Hospital, UCSF Benioff Children's Hospitals, The Royal Marsden, Guy's and St Thomas' NHS Foundation Trust.
Diagnosis integrates clinical assessment, echocardiography, computed tomography angiography or magnetic resonance angiography often performed at radiology departments like Mayo Clinic Radiology, Mount Sinai Imaging, UCLA Radiology, Royal Marsden Imaging. Genetic testing panels from Invitae, GeneDx, Ambry Genetics, Quest Diagnostics confirm causative variants; variant interpretation follows standards from American College of Medical Genetics and Genomics, European Society of Human Genetics, ClinGen frameworks. Multidisciplinary diagnostic conferences at centers such as Johns Hopkins, Massachusetts General Hospital, Great Ormond Street Hospital and institutions like Children's National Hospital integrate cardiology, genetics, and radiology findings. Prenatal diagnosis and preimplantation genetic diagnosis are offered through reproductive medicine programs at UCSF Medical Center, Cornell Medicine, Guy's Hospital.
Management focuses on surveillance and prevention of vascular events with beta-blockers, angiotensin receptor blockers and individualized antihypertensive regimens guided by cardiology services at Cleveland Clinic Heart & Vascular Institute, Mayo Clinic Heart Failure Program, Mount Sinai Heart. Prophylactic aortic root replacement and endovascular or open repair of peripheral aneurysms are performed by cardiothoracic and vascular surgeons at Cleveland Clinic Heart and Vascular Institute, German Heart Center Munich, Baylor St. Luke's Medical Center, Karolinska University Hospital. Orthopedic, craniofacial, ENT and dental interventions coordinate with teams at Boston Children's Hospital, Great Ormond Street Hospital, Hospital for Sick Children (Toronto), St. Thomas' Hospital. Ongoing clinical trials and translational studies at NIH Clinical Center, National Institutes of Health, European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart, European Commission Horizon investigate TGF-beta pathway modulators and gene-based therapies. Lifestyle counseling and patient advocacy involve organizations like Marfan Foundation, Genetic and Rare Diseases Information Center, European Society of Cardiology, American Heart Association.
Life expectancy varies with vascular involvement; major complications include aortic dissection, arterial rupture, cerebrovascular events, and organ ischemia managed in intensive care units at Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, UCSF Medical Center. Pregnancy carries elevated maternal and fetal risk requiring high-risk obstetrics at centers such as Mount Sinai Health System, Cleveland Clinic Maternal-Fetal Medicine, Baylor College of Medicine, Karolinska University Hospital. Long-term morbidity includes chronic pain, hearing loss, and neurocognitive sequelae addressed by rehabilitation programs at Sheba Medical Center, Spaulding Rehabilitation Hospital, Hôpital Pitié-Salpêtrière.
The condition is rare with prevalence estimates derived from cohorts assembled at reference centers including Mayo Clinic, Johns Hopkins, Great Ormond Street Hospital, Erasmus MC. Case series and registry data from European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart, Marfan Foundation Registry, National Organization for Rare Disorders inform age of onset, sex distribution, and mutation frequency. Population genetics studies at Wellcome Sanger Institute, 1000 Genomes Project, Exome Aggregation Consortium contribute allele frequency data and variant interpretation frameworks used by ClinVar, HGMD.
First described in clinical reports by multidisciplinary teams, subsequent gene discovery was achieved through collaborations among investigators at Johns Hopkins University School of Medicine, Cedars-Sinai Medical Center, Mayo Clinic, Massachusetts General Hospital and research consortia including Howard Hughes Medical Institute, Broad Institute, Wellcome Trust. Landmark publications in journals affiliated with Nature Publishing Group, The Lancet, The New England Journal of Medicine, Journal of the American Medical Association delineated genotype-phenotype correlations and surgical thresholds. Ongoing research programs and clinical networks at NIH Clinical Center, European Commission Horizon 2020, Canadian Institutes of Health Research, Australian National Health and Medical Research Council continue to refine management and explore molecular therapies.
Category:Rare genetic disorders